Historical record - last NADAC effective date: 8/18/2021
Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1113 per EA under NDC 29300035010. Its NADAC has been published 99 times since Oct 2, 2019.
FDA first approved this application on Mar 12, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300035010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/18/2021
Active Ingredients
ALLOPURINOLApproval Type
Generic (ANDA)
FDA Application
ANDA211820FDA Approved
3/12/2019
TE Code
AB
On Market Since
3/12/2019
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 99 times since Oct 2, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1113 per EA |
|---|---|
| All-time high | $0.1172 (Jul 15, 2020) |
| All-time low | $0.0814 (Mar 17, 2021) |
| Median price | $0.1019 |
| Average price | $0.1017 |
| Largest weekly change | -16.5% (Jul 22, 2020) |
| Weeks tracked | 99 |
| Tracking since | Oct 2, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+0.9%
Last surveyed Aug 18, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1113 per EA (NDC 29300035010), effective Aug 18, 2021.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 99 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since Oct 2, 2019, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0814 (Mar 17, 2021) to a high of $0.1172 (Jul 15, 2020), with a median of $0.1019 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLOPURINOL 300 MG TABLET, is $0.0546 per EA — about 51% below ALLOPURINOL 300 MG TABLET.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 29300035010) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.